| Primary |
| Product Used For Unknown Indication |
21.7% |
| Depression |
10.9% |
| Hypertension |
8.7% |
| Fibromyalgia |
6.5% |
| Immunisation |
6.5% |
| Cholecystitis Infective |
4.3% |
| Gallbladder Pain |
4.3% |
| Infection |
4.3% |
| Mental Disorder |
4.3% |
| Rheumatoid Arthritis |
4.3% |
| Vertigo |
4.3% |
| Analgesic Therapy |
2.2% |
| Anxiety |
2.2% |
| Arthritis |
2.2% |
| Blood Cholesterol Abnormal |
2.2% |
| Blood Glucose Abnormal |
2.2% |
| Cardiac Disorder |
2.2% |
| Diuretic Therapy |
2.2% |
| Drug Hypersensitivity |
2.2% |
| Emphysema |
2.2% |
|
| Drug Hypersensitivity |
75.0% |
| No Adverse Event |
12.0% |
| Hypersensitivity |
3.2% |
| Rash |
2.9% |
| Urticaria |
2.0% |
| Anaphylactic Reaction |
1.0% |
| Dyspnoea |
0.8% |
| Anaphylactic Shock |
0.5% |
| Injection Site Pain |
0.5% |
| Pruritus |
0.3% |
| Allergy To Arthropod Sting |
0.2% |
| Cerebrovascular Accident |
0.2% |
| Death |
0.2% |
| Diarrhoea |
0.2% |
| Dysstasia |
0.2% |
| Eye Swelling |
0.2% |
| Malaise |
0.2% |
| Nausea |
0.2% |
| Oedema |
0.2% |
| Pharyngeal Oedema |
0.2% |
|
| Secondary |
| Antibiotic Therapy |
15.8% |
| Diabetes Mellitus |
13.2% |
| Coronary Artery Disease |
7.9% |
| Endocarditis Bacterial |
7.9% |
| Product Used For Unknown Indication |
7.9% |
| Hyperlipidaemia |
5.3% |
| Infection |
5.3% |
| Myocardial Infarction |
5.3% |
| Angiopathy |
2.6% |
| Asthma |
2.6% |
| Cellulitis |
2.6% |
| Chronic Sinusitis |
2.6% |
| Hormone Level Abnormal |
2.6% |
| Hypersensitivity |
2.6% |
| Hypertension |
2.6% |
| Hypothyroidism |
2.6% |
| Lyme Disease |
2.6% |
| Oedema |
2.6% |
| Sinusitis |
2.6% |
| Thyroid Cancer |
2.6% |
|
| Drug Hypersensitivity |
66.7% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.2% |
| Inflammation |
4.2% |
| Nausea |
4.2% |
| Oedema Peripheral |
4.2% |
| Pruritus |
4.2% |
| Rash |
4.2% |
| Urticaria |
4.2% |
| Weight Decreased |
4.2% |
|
| Concomitant |
| Inflammatory Bowel Disease |
100.0% |
|
| Acute Respiratory Distress Syndrome |
100.0% |
|
| Interacting |
| Ear Infection |
50.0% |
| Supplementation Therapy |
50.0% |
|
|
